QCBGMYHLQLQLLH-UHFFFAOYSA-N
C26H36F6N6O5Si — CID 151558911
Data last refreshed: (MolForge compound catalog, from PubChem)
About QCBGMYHLQLQLLH-UHFFFAOYSA-N
QCBGMYHLQLQLLH-UHFFFAOYSA-N (PubChem CID 151558911) has the molecular formula C26H36F6N6O5Si and a molecular weight of 654.69 g/mol. Its IUPAC name is 5-[2-[3-oxo-3-[4-[5-(trifluoromethyl)pyrimidin-2-yl]piperazin-1-yl]propoxy]propoxy]-4-(trifluoromethyl)-2-(2-trimethylsilylethoxymethyl)pyridazin-3-one.
Molecular Properties
| Compound Name | QCBGMYHLQLQLLH-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 151558911 |
| Molecular Formula | C26H36F6N6O5Si |
| Molecular Weight | 654.69 g/mol |
| Exact Mass | 654.24 |
| IUPAC Name | 5-[2-[3-oxo-3-[4-[5-(trifluoromethyl)pyrimidin-2-yl]piperazin-1-yl]propoxy]propoxy]-4-(trifluoromethyl)-2-(2-trimethylsilylethoxymethyl)pyridazin-3-one |
| SMILES | CC(COc1cnn(COCC[Si](C)(C)C)c(=O)c1C(F)(F)F)OCCC(=O)N1CCN(c2ncc(C(F)(F)F)cn2)CC1 |
| InChI | InChI=1S/C26H36F6N6O5Si/c1-18(16-43-20-15-35-38(17-41-11-12-44(2,3)4)23(40)22(20)26(30,31)32)42-10-5-21(39)36-6-8-37(9-7-36)24-33-13-19(14-34-24)25(27,28)29/h13-15,18H,5-12,16-17H2,1-4H3 |
| InChIKey | QCBGMYHLQLQLLH-UHFFFAOYSA-N |
| XLogP | 3.91 |
| TPSA | 111.91 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 654.69 |
| LogP ≤ 5 | 3.91 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 151558911 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.